Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray which protects against common cold, can help shorten the duration of a common cold if used at an early stage of the infection, alleviates common cold symptoms and soothes sore throat. Our head office is in Lund, Sweden, but we also have an office in Reykjavik, Iceland. For product info, please visit at www.coldzyme.co.uk.
Looking for a particular Enzymatica AB employee's phone or email?
The Enzymatica AB annual revenue was $80.8 million in 2026.
Claus Egstrand is the CEO of Enzymatica AB.
17 people are employed at Enzymatica AB.
Enzymatica AB is based in Lund, Skane.
The NAICS codes for Enzymatica AB are [54171, 541, 54, 5417, 541713].
The SIC codes for Enzymatica AB are [87, 873].